Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma

: Zoerner, A.A.; Stichtenoth, D.O.; Engeli, S.; Batkai, S.; Winkler, Carla; Schaumann, Frank; Janke, J.; Holz, Olaf; Krug, Norbert; Tsikas, D.; Jordan, J.; Hohlfeld, Jens Michael


Clinical Pharmacology and Therapeutics 90 (2011), No.3, pp.388-391
ISSN: 0009-9236
Journal Article
Fraunhofer ITEM ()
arachidonic acid; bronchial provocation test; Bronchoalveolar lavage fluid; endocannabinoids; polyunsaturated alkamides; receptor; cannabinoid; CB2; allergen; asthma; inflammation

Preclinical studies suggest that the endocannabinoid anandamide restrains allergic airway obstruction and inflammation. Therefore, we applied saline or allergens via bronchoscopy into different lung segments of patients with allergic asthma. Twenty-four hours later, anandamide concentrations in bronchoalveolar lavage fluids had increased more than fourfold. Anandamide concentrations correlated with severity of airway inflammation. These observations suggest that allergen exposure specifically activates the pulmonary endocannabinoid system (ECS) in patients with allergic asthma.